OrbisCure ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About OrbisCure ApS
OrbisCure ApS (CVR number: 39315394) is a company from AARHUS. The company recorded a gross profit of -639.4 kDKK in 2024. The operating profit was -2435.4 kDKK, while net earnings were -1991.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -28.4 %, which can be considered poor and Return on Equity (ROE) was -35.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 51.3 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. OrbisCure ApS's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -73.31 | 137.36 | 16.51 | - 314.19 | - 639.37 |
EBIT | - 375.27 | - 170.85 | - 634.52 | -1 602.22 | -2 435.44 |
Net earnings | - 301.68 | - 138.54 | - 557.42 | 761.13 | -1 991.67 |
Shareholders equity total | 1 847.53 | 1 708.99 | 1 651.58 | 6 648.09 | 4 656.42 |
Balance sheet total (assets) | 2 239.46 | 3 128.83 | 4 450.67 | 8 021.73 | 9 087.94 |
Net debt | -1 415.81 | 352.91 | -54.91 | -1 252.70 | 2 429.85 |
Profitability | |||||
EBIT-% | |||||
ROA | -30.8 % | -6.4 % | -16.7 % | 7.7 % | -28.4 % |
ROE | -30.2 % | -7.8 % | -33.2 % | 18.3 % | -35.2 % |
ROI | -37.2 % | -7.2 % | -26.4 % | 10.1 % | -29.5 % |
Economic value added (EVA) | - 300.60 | - 137.77 | - 479.46 | -1 074.57 | -1 957.97 |
Solvency | |||||
Equity ratio | 82.5 % | 54.6 % | 37.1 % | 82.9 % | 51.3 % |
Gearing | 0.8 % | 58.8 % | 8.2 % | 82.6 % | |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 4.3 | 0.9 | 0.2 | 2.9 | 0.7 |
Current ratio | 4.3 | 0.9 | 0.2 | 2.9 | 0.6 |
Cash and cash equivalents | 1 431.49 | 652.69 | 54.91 | 1 795.10 | 1 414.97 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BBB | BB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.